• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Drug dosing in renal disease.肾脏疾病中的药物剂量
Clin Biochem Rev. 2011 May;32(2):69-73.
2
Renal Failure Drug Dose Adjustments肾衰竭药物剂量调整
3
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function.抗癌药物的肾毒性与消除:肾功能改变时的给药指南
Cancer Treat Rev. 1995 Jan;21(1):33-64. doi: 10.1016/0305-7372(95)90010-1.
4
Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting.临床决策支持与学术细化相结合,可改善医院环境中关键经肾清除药物的处方。
J Am Med Inform Assoc. 2010 May-Jun;17(3):308-12. doi: 10.1136/jamia.2009.001537.
5
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.肾功能损害患者中血管紧张素转换酶抑制剂的药代动力学。
J Hypertens Suppl. 1989 Sep;7(5):S29-32.
6
Strength of evidence for labeled dosing recommendations in renal impairment.肾功能损害时标记剂量推荐的证据强度。
Clin Trials. 2017 Apr;14(2):219-221. doi: 10.1177/1740774516673818. Epub 2016 Oct 25.
7
Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease.监管视角下的设计药代动力学研究和为慢性肾脏病患者优化标签推荐。
J Clin Pharmacol. 2012 Jan;52(1 Suppl):79S-90S. doi: 10.1177/0091270011415410.
8
Antibiotic dosing adjustments in patients with declined kidney function at a tertiary hospital in Jordan.约旦一家三级医院肾功能下降患者的抗生素剂量调整。
Int J Clin Pract. 2020 Oct;74(10):e13579. doi: 10.1111/ijcp.13579. Epub 2020 Jun 25.
9
Computerized drug dosing in renal failure: a real problem and a practical solution.肾衰竭中的计算机化药物剂量计算:一个实际问题及切实可行的解决方案。
J Trauma. 1978 May;18(5):308-16. doi: 10.1097/00005373-197805000-00003.
10
Drug therapy management in patients with renal impairment: how to use creatinine-based formulas in clinical practice.肾功能损害患者的药物治疗管理:如何在临床实践中使用基于肌酐的公式
Eur J Clin Pharmacol. 2016 Dec;72(12):1433-1439. doi: 10.1007/s00228-016-2113-2. Epub 2016 Aug 27.

引用本文的文献

1
Antimicrobial resistance: Current challenges and future directions.抗菌药物耐药性:当前挑战与未来方向。
Med J Armed Forces India. 2025 May-Jun;81(3):247-258. doi: 10.1016/j.mjafi.2024.07.006. Epub 2024 Sep 19.
2
Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid® prescribing: a descriptive analysis.帕罗韦德(Paxlovid®)处方中药物相关问题的频率、类型和严重程度以及药剂师的干预措施:一项描述性分析
Int J Clin Pharm. 2025 Apr;47(2):471-476. doi: 10.1007/s11096-024-01852-5. Epub 2024 Dec 21.
3
Renal Impairment and Dose Adjustment of Long-Acting Injectable Antipsychotics: Are We Getting It Right? A Case Report.长效注射用抗精神病药物的肾损害与剂量调整:我们做得对吗?一例病例报告。
Focus (Am Psychiatr Publ). 2024 Oct;22(4):492-494. doi: 10.1176/appi.focus.20240007. Epub 2024 Oct 15.
4
Evolving Concepts of Pain Management in Elderly Patients.老年患者疼痛管理理念的演变。
Curr Pain Headache Rep. 2024 Oct;28(10):999-1005. doi: 10.1007/s11916-024-01291-x. Epub 2024 Jul 5.
5
Heart Failure in Patients with Chronic Kidney Disease.慢性肾脏病患者的心力衰竭
J Clin Med. 2023 Sep 21;12(18):6105. doi: 10.3390/jcm12186105.
6
Ultrathin, elastic, and self-adhesive nanofiber bio-tape: An intraoperative drug-loading module for ureteral stents with localized and controlled drug delivery properties for customized therapy.超薄、弹性且自粘的纳米纤维生物胶带:一种用于输尿管支架的术中载药模块,具有局部和可控的药物递送特性,用于定制治疗。
Bioact Mater. 2022 Mar 22;18:128-137. doi: 10.1016/j.bioactmat.2022.03.025. eCollection 2022 Dec.
7
Dose banding - Weighing up benefits, risks and therapeutic failure.剂量捆绑 - 权衡利弊、风险和治疗失败。
Br J Clin Pharmacol. 2022 Jul;88(7):3474-3482. doi: 10.1111/bcp.15307. Epub 2022 Mar 24.
8
Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.患有慢性肾病的犬猫的药物剂量调整
Animals (Basel). 2022 Jan 21;12(3):262. doi: 10.3390/ani12030262.
9
Medicine Dose Adjustment Practice and Associated Factors among Renally Impaired Patients in Amhara Regional State, Ethiopia.埃塞俄比亚阿姆哈拉州肾功能受损患者的药物剂量调整实践及相关因素
Int J Nephrol. 2021 Dec 1;2021:8238250. doi: 10.1155/2021/8238250. eCollection 2021.
10
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.药物遗传学在药物不良反应中的作用:向个性化医学发展的最新进展
Front Pharmacol. 2021 Apr 30;12:651720. doi: 10.3389/fphar.2021.651720. eCollection 2021.

本文引用的文献

1
Estimating renal function for drug dosing decisions.评估肾功能以做出药物剂量决策。
Clin Biochem Rev. 2011 May;32(2):81-8.
2
Methods of Estimating GFR - Different Equations Including CKD-EPI.估算肾小球滤过率(GFR)的方法 - 包括慢性肾脏病流行病学合作(CKD-EPI)方程在内的不同方程
Clin Biochem Rev. 2011 May;32(2):75-9.
3
Mechanistic basis of using body size and maturation to predict clearance in humans.利用体型和成熟度预测人体清除率的机制基础。
Drug Metab Pharmacokinet. 2009;24(1):25-36. doi: 10.2133/dmpk.24.25.
4
Individualized compared with conventional dosing of enoxaparin.依诺肝素个体化给药与传统给药的比较。
Clin Pharmacol Ther. 2008 Jun;83(6):882-8. doi: 10.1038/sj.clpt.6100399. Epub 2007 Oct 10.
5
Quantification of lean bodyweight.瘦体重的量化
Clin Pharmacokinet. 2005;44(10):1051-65. doi: 10.2165/00003088-200544100-00004.
6
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.一种根据血清肌酐估算肾小球滤过率的更准确方法:一个新的预测方程。肾脏病饮食改良研究组。
Ann Intern Med. 1999 Mar 16;130(6):461-70. doi: 10.7326/0003-4819-130-6-199903160-00002.
7
Prediction of creatinine clearance from serum creatinine.根据血清肌酐预测肌酐清除率。
Nephron. 1976;16(1):31-41. doi: 10.1159/000180580.

肾脏疾病中的药物剂量

Drug dosing in renal disease.

作者信息

Doogue Matthew P, Polasek Thomas M

机构信息

Department of Clinical Pharmacology, Flinders University.

出版信息

Clin Biochem Rev. 2011 May;32(2):69-73.

PMID:21611079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100283/
Abstract

Renal disease alters the effects of many drugs, particularly when active drug moieties are renally cleared. Drug doses should usually be reduced in renal disease in proportion to the predicted reduction in clearance of the active drug moiety. Patient factors to consider in adjusting drug doses include the degree of renal impairment and patient size. Drug factors to consider in adjusting doses include the fraction of the drug excreted unchanged in urine and the drug's therapeutic index. Estimates of renal function are useful to guide dosing of renally cleared drugs with medium therapeutic indices, but are not precise enough to guide dosing of drugs with narrow therapeutic indices. This article discusses principles of drug dose adjustment in renal disease.

摘要

肾脏疾病会改变许多药物的作用,尤其是当活性药物部分通过肾脏清除时。在肾脏疾病中,药物剂量通常应根据活性药物部分清除率的预计降低幅度相应减少。调整药物剂量时应考虑的患者因素包括肾功能损害程度和患者体型。调整剂量时应考虑的药物因素包括药物以原形经尿液排泄的比例和药物的治疗指数。肾功能评估有助于指导治疗指数中等的经肾脏清除药物的给药,但不够精确,无法指导治疗指数窄的药物给药。本文讨论了肾脏疾病中药物剂量调整的原则。